Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
5,644
Funds Holding Change
+46
Funds Holding Growth
+0.8%
Value
$1.51T
Holding in Top 10
791
Top 10 Change
+112
Top 10 Growth
+16%
Value Growth
+10%
New
261
Increased
2,528
Reduced
2,485
Closed
131
Capital Inflow
$33.4B
Capital Outflow
$64.7B
Net Capital Flow
-$31.4B
Capital Flow Change
-$35B
Calls
$24.5B
Puts
$21.1B
Net Calls
+$3.43B
Put/Call Ratio
0.86